Skip to main content
UG
NASDAQ Industrial Applications And Services

United-Guardian Q3 Net Income Jumps 247% on 54% Sales Growth

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
7
Price
$6.71
Mkt Cap
$30.828M
52W Low
$5.575
52W High
$8.45
52W Position info
20% above low
Off High info
21% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

UG sits 20% above its 52-week low of $5.575.

Summary

United-Guardian reported third-quarter sales up 54% to $3.49 million and net income up 247% to $930,912, with all three product lines growing.


Key Events · Earnings and Guidance · UG

  • Q3 Sales Up 54%, Net Income Up 247%

    Net sales rose to $3,494,780 from $2,264,261, and net income reached $930,912 ($0.20 per share) versus $268,441 ($0.06 per share) a year ago.

  • All Three Product Lines Grew

    Pharmaceutical sales rose 29%, led by Renacidin; cosmetic ingredient sales surged 187% on higher Ashland purchases; and medical lubricants grew 20% on an India customer.

  • Nine-Month Earnings $0.54 Per Share

    Year-to-date net sales of $9,475,269 were up 25%, and net income of $2,478,393 was up 70% from $1,456,162 ($0.32 per share).

  • New Personal Care Product Planned

    Management said a new personal care product is in late-stage development, with launch planned for early next year.


Analysis · UG · Industrial Applications And Services

Net income nearly tripled to $930,912 ($0.20 per share) from $268,441 a year earlier, while sales climbed 54% to $3.49 million. The growth was broad-based: pharmaceutical sales rose 29% on Renacidin and expanded formulary coverage, cosmetic ingredients surged 187% on higher purchases from marketing partner Ashland, and medical lubricants grew 20%. For a company this small, a quarter of this size marks a meaningful step-change in earnings power, and the nine-month figures ($0.54 per share versus $0.32) confirm it is a trend rather than a one-off order. Management also flagged a new personal care product in late-stage development, targeted for launch early next year.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, UG was trading at $6.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $30.8M. The 52-week trading range was $5.58 to $8.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UG - Latest Insights

UG
Aug 07, 2026, 10:42 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.11
Real-time Price: $6.71 info
Change: -$0.400 (-6%) info
Market Cap: $30.828M info
UG
May 12, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.10
Real-time Price: $6.71 info
Change: -$0.390 (-5%) info
Market Cap: $30.828M info
UG
May 08, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.00
Real-time Price: $6.71 info
Change: -$0.290 (-4%) info
Market Cap: $30.828M info
UG
Apr 06, 2026, 12:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $6.60
Real-time Price: $6.71 info
Change: +$0.110 (+2%) info
Market Cap: $30.828M info
UG
Mar 27, 2026, 9:00 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $6.71 info
Change: +$0.460 (+7%) info
Market Cap: $30.828M info